Abstract: An integrated solar cell system applies energy created by a solar cell module. The integration system includes a solar cell module, a low-grade heat recovery means, and a process system. The low-grade heat recovery means recovers waste heat from the solar cell module and connects the solar cell module to the process system. The process system is powered at least partially by thermal energy derived from waste heat generated by the solar cell module.

Abstract: The invention relates to linear y-carboxyglutamate rich conotoxins, derivatives or pharmaceutically acceptable salts thereof, and uses thereof, including the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, as neuroprotective agents or for the management of pain. The invention further relates to nucleic acid sequences encoding the conopeptides and encoding propeptides, as well as the propeptides.

Abstract: This invention relates to relatively short peptides about 25-40 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogs to the naturally available peptides, and which include three cyclizing disulfide linkages and one or more ?carboxyglutamate residues.

Abstract: A method of providing health care by establishing a predetermined patient population grouped by geographic regions where the patient population has access to a traveling healthcare professional that may travel to the patient's location. The healthcare professional evaluates and examines the patient using a plurality of technologies including a microprocessor and memory storage that is coupled to, or interfaced with, audio/video/data transfer and communications systems, medical devices, and other vital measurement devices that the physician located at the physicians' center uses to assess and consult the healthcare professional who is onsite with the remote patient. During the exam the healthcare professional uses audio/video/data communications for interconnecting the healthcare professional with a physician at the physicians' center.

Abstract: The invention relates to ?-carboxyglutamate containing conopeptides, derivatives or pharmaceutically acceptable salts thereof, and uses thereof, including the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, as neuroprotective agents or for the management of pain. The invention further relates to nucleic acid sequences encoding the conopeptides and encoding propeptides, as well as the propeptides.

Abstract: An article of manufacture for ballet shoes and shank, with a shank for a ballet shoe, with improved durability, that is formed of flexible thermoplastic material and is adapted to be located in the sole of the ballet shoe between an inner liner and an outer sole. The flexibility and support characteristics of the shank may be tailored to a particular dancer by varying the type, and/or thickness of material, or by varying the thickness of material along the shank.

Abstract: An impeller for use in a centrifugal pump, the impeller (20) including a shroud having opposed faces, an outer peripheral edge portion and a rotation axis, a plurality of pumping vanes on one of the faces of the shroud and extending away from the rotation axis each pumping vane having an outer peripheral edge portion, and a plurality of auxiliary vanes (26) on the other face of the shroud, the auxiliary vanes of each having an outer edge portion wherein the dimension Da from the rotation axis to the outer peripheral edge portion of the shroud is greater than the dimension Db from the rotation axis to the outer edge portion of the auxiliary vanes.

Abstract: In accordance with the present invention, an impeller for use in a centrifugal pump has at least one vane the radially outer terminal end of which is configured to produce a flow velocity profile that controls and reduces the wear caused by slurry fluid being expelled from the impeller on the inner surface of the pump casing. The impeller vanes of the present invention are generally configured with a radially outwardly extending portion, as compared with the conventional straight or concave edge of an impeller vane. The outwardly extending portion may vary in shape, but is selected to produce a flow velocity profile that reduces wear in the pump casing.

Abstract: The present invention is directed to conotoxin peptides, derivatives or pharmaceutically acceptable salts thereof. The present invention is further directed to the use of this peptide, derivatives thereof and pharmaceutically acceptable salts thereof for the treatment of disorders associated with voltage-gated ion channels, voltage-gated ligand channels and/or receptors. The invention is further directed to nucleic acid sequences encoding the conotoxin peptides and encoding propeptides, as well as the propeptides.

Abstract: A pump casing for a centrifugal pump of the type that is used to process abrasive slurries is disclosed having at least one side or side liner that has a radially extending portion oriented toward the cutwater of the pump casing to localize the abrasive wear caused by the abrasive slurries to the side of the pump casing. The side liner of the pump is configured with a perimeter edge that is non-circular. The pump casing may preferably be configured with an open cutwater configuration or other suitable configuration for localizing wear to the sides of the casing.

Abstract: The invention relates to linear ?-carboxyglutamate rich conotoxins, derivatives or pharmaceutically acceptable salts thereof, and uses thereof, including the treatment of neurologic and psychiatric disorders, such as anticonvillsant agents, as neuroprotective agents or for the management of pain. The invention further relates to nucleic acid sequences encoding the conopeptides and encoding propeptides, as well as the propeptides.

Abstract: The invention relates to relatively short peptides (termed ?-conotoxins herein), about 10-25 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include two disulfide bonds.

Abstract: The invention relates to relatively short peptides (termed 1-conotoxins herein), about 30-50 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include four disulfide bonds.

Abstract: A Faraday system for measuring ion beam current in an ion implanter or other ion beam treatment system includes a Faraday cup body defining a chamber which has an entrance aperture for receiving an ion beam, a suppression electrode positioned in proximity to the entrance aperture to produce electric fields for inhibiting escape of electrons from the chamber, and a magnet assembly positioned to produce magnetic fields for inhibiting escape of electrons from the chamber. The chamber may have a relatively small ratio of chamber depth to entrance aperture width.

Abstract: The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues. The contantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.

Abstract: The invention relates to relatively short peptides (termed &tgr;-conotoxins herein), about 10-25 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include two disulfide bonds.

Abstract: This invention relates to relatively short peptides about 25-40 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogs to the naturally available peptides, and which include three cyclizing disulfide linkages and one or more &ggr;-carboxyglutamate residues.

Abstract: The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues. The conantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.

Abstract: A Faraday system for measuring ion beam current in an ion implanter or other ion beam treatment system includes a Faraday cup body defining a chamber which has an entrance aperture for receiving an ion beam, a suppression electrode positioned in proximity to the entrance aperture to produce electric fields for inhibiting escape of electrons from the chamber, and a magnet assembly positioned to produce magnetic fields for inhibiting escape of electrons from the chamber. The chamber may have a relatively small ratio of chamber depth to entrance aperture width.